Almost two years after abandoning its vaccine thanks to false positive HIV test results, the University of Queensland is entering human trials again on its homegrown savour from COVID.
Insight – Making modern medicines in Australia miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
MIL-OSI Australia: Insight – Making modern medicines in Australia foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
Appointment of Professor Trent Munro as Senior Vice President of Therapeutics.Professor Munro has over 25 years’ research and development experience, including with multinational biopharmaceutical company Amgen based in California, United States.Professor Munro has recently held several leadership roles in Australia.
Process intensification is an essential component of Biopharma 4.0, a framework built on real-time monitoring, artificial intelligence, process optimization, and overall efficiency. Suppliers and sponsors are driving these initiatives, including through innovations in critical unit operations. Given that antibody drugs produced in mammalian (primarily CHO) expression systems comprise 75 percent of total biopharma sales, cell culture is the natural place to look for process efficiencies.